Repligen Corp (RGEN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Repligen Corp (RGEN)

RGEN 149.37

-4.5%

Jan 30 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Harvey Allen who wrote (379)	1/3/2008 11:18:26 AM
From: Bob Laz	Read Replies (1) of 395

harvey - Good stuff as far as Fred Ataxia & the Scripts Institute. Is this a joint effort with our RGEN staff & Dr Gottesfeld at Scrpts or do he and his staff do all of the research? Sort of dismissed this as well as Secretin for functional MRI due to the relatively small (estimate $30M from discussion with former CFO)revenue potential - maybe not giving them just consideration. Any idea how large Fred Ataxia market is? In any event still wish and hope to wake up to $12-$15 but happy with any and all incremental progress - wonder when announcement on use of cash / purchase company / purchase patents - believe any news will be taken as positive and move us up - in the case of an acquisition that could move us 50 cents to a buck.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next